Actos Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
Condition:   Type2 Diabetes Interventions:   Drug: Metformin≥1000mg + Dapagliflozin 10mg;   Drug: Pioglitazone 15mg;   Drug: Pioglitazone 30 mg;   Drug: Pioglitazone 15mg Placebo;   Drug: Pioglitazone 30mg Placebo Sponsor:   Boryung Pharmaceutical Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2021 Category: Research Source Type: clinical trials

A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
Condition:   Type2 Diabetes Interventions:   Drug: Metformin≥1000mg;   Drug: Pioglitazone 15mg;   Drug: Pioglitazone 30 mg;   Drug: Pioglitazone 15mg Placebo;   Drug: Pioglitazone 30mg Placebo;   Drug: Dapagliflozin 10mg Sponsor:   Boryung Pharmaceutical Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2021 Category: Research Source Type: clinical trials

Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment
Conditions:   Chronic Myelogenous Leukemia, BCR-ABL Positive;   CML, Chronic Phase Intervention:   Drug: Pioglitazone 15mg Sponsor:   Mansoura University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2021 Category: Research Source Type: clinical trials